New at Prodigy Blog A collection of articles about our people, our capabilities, our industry, and everything in between. Sarah Cirildo 6/17/26 Sarah Cirildo 6/17/26 Microdosing GLP‑1s: What the Early Evidence Says About Safety, Dosing, and Risk Read More Sarah Cirildo 6/10/26 Sarah Cirildo 6/10/26 The Expanding Role of GLP‑1 Therapies: Where Foundayo Fits in Workers’ Compensation Read More Sarah Cirildo 4/29/26 Sarah Cirildo 4/29/26 Compounded Medications: Risks, Costs, and the Impact on Workers’ Compensation Read More Del Doherty 7/4/25 Del Doherty 7/4/25 GLP-1 Medications: What You Need to Know About Side Effects Read More Del Doherty 6/27/25 Del Doherty 6/27/25 Moving Beyond Blood Sugar – The Role of GLP-1s (Ozempic, Wegovy) in Cardiovascular Disease Prevention Read More Del Doherty 6/6/25 Del Doherty 6/6/25 GLP-1s: What They Are, What They Do, and Where They Fit in Workers’ Comp Read More Older Posts
Sarah Cirildo 6/17/26 Sarah Cirildo 6/17/26 Microdosing GLP‑1s: What the Early Evidence Says About Safety, Dosing, and Risk Read More
Sarah Cirildo 6/10/26 Sarah Cirildo 6/10/26 The Expanding Role of GLP‑1 Therapies: Where Foundayo Fits in Workers’ Compensation Read More
Sarah Cirildo 4/29/26 Sarah Cirildo 4/29/26 Compounded Medications: Risks, Costs, and the Impact on Workers’ Compensation Read More
Del Doherty 7/4/25 Del Doherty 7/4/25 GLP-1 Medications: What You Need to Know About Side Effects Read More
Del Doherty 6/27/25 Del Doherty 6/27/25 Moving Beyond Blood Sugar – The Role of GLP-1s (Ozempic, Wegovy) in Cardiovascular Disease Prevention Read More
Del Doherty 6/6/25 Del Doherty 6/6/25 GLP-1s: What They Are, What They Do, and Where They Fit in Workers’ Comp Read More